secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001493152-24-022329
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech raises $2.0M in registered direct offering and warrant placement
-------------------------------------------------------------------------------

- Issues 5,640,958 shares at $0.363/share for gross proceeds of ~$2.0M to a single institutional investor.
- Concurrent private placement of Class A and B warrants to purchase up to 5,640,958 shares each, exercisable at $0.363.
- Class A warrants exercisable after 6 months, expire 18 months later; Class B warrants expire 5 years after exercise date.
- Officers and directors agree to 90-day lock-up; company restricted from issuing equity for 60 days (30-day ATM exception).
- Maxim Group LLC serving as placement agent with 8% cash fee and expense reimbursement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315224022329/0001493152-24-022329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315224022329/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-022329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer